Evidence map›Paper›PMID 38185888›Full record

ArticleCurrent medicinal chemistry2024

Is Oxidized Low-Density Lipoprotein a Principal Actor in Atherogenesis?

Alexander Orekhov, Vasily Sukhorukov, Alexandra Melnichenko

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Current medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06590012 (Prospective Double-Blinded Randomized Placebo-controlled Multicenter Study Evaluating the Impact of Dietary Supplement "Tertinat" on Major Adverse Cardiovascular Events in ATherosclerotic Patients After Coronary Revascularization Surgery.), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06590012 phase2active not recruitingnot on this map

Prospective Double-Blinded Randomized Placebo-controlled Multicenter Study Evaluating the Impact of Dietary Supplement "Tertinat" on Major Adverse Cardiovascular Events in ATherosclerotic Patients After Coronary Revascularization Surgery.

TypeinterventionalSponsorInstitute for Atherosclerosis Research, RussiaRan2024 to 2027Enrolled1,228ConditionsAtherosclerosis, Atheroscleroses, Coronary, Carotid AtherosclerosisArmsPlacebo, Tertinat
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alexander OrekhovLaboratory of Angiopatology, Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, Moscow 125315, Russia.ORCID 0000-0002-6495-1628
Vasily SukhorukovLaboratory of Angiopatology, Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, Moscow 125315, Russia.
Alexandra MelnichenkoLaboratory of Angiopatology, Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, Moscow 125315, Russia.
Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences · RU

Funding

Russian Science Foundation 23-65-10014
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Atherogenesisautoantibodies against LDLdesialylated LDLelectronegative LDLmalondialdehyde treated LDLmultiple-modified LDLoxidized LDLsmall dense LDL.

Identifiers

PMID38185888
OpenAlexW4390666861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.